Tag: biopreservation global market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Biopreservation Market Increase Between 2026 And 2030?

The bioprocess bags market size has experienced rapid growth in recent years. It is anticipated to expand from $3.83 billion in 2025 to $4.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.1%. The historical expansion of this market can be ascribed to the surge in biopharmaceutical manufacturing, the increasing uptake of disposable technologies, the broadening of contract manufacturing services, a heightened focus on process flexibility, and the availability of standardized single-use components.

The bioprocess bags market is poised for substantial expansion over the next few years, projected to achieve a size of $8.14 billion by 2030, growing at a compound annual growth rate (CAGR) of 16.3%. This growth during the forecast period is primarily driven by an escalating demand for biologics and vaccines, the expansion of cell and gene therapy manufacturing, increased investments in modular bioprocessing facilities, a rising focus on efficient manufacturing costs, and enhanced regulatory support for single-use systems. Significant trends anticipated include the broader adoption of single-use bioprocessing systems, an increasing need for sterile disposable containers, the expanding utilization of 3D bioprocess bags in cell culture, the development of more flexible manufacturing workflows, and a reinforced emphasis on mitigating contamination risks.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8263&type=smp

What Primary Factors Are Fueling The Expansion Of The Biopreservation Market?

The quick expansion of biotechnology firms is projected to advance the bioprocess bag market’s development in the future. Biotechnology companies utilize biological understanding, instruments, and methods to create goods and services for diverse sectors. Bioprocess bags offer multiple advantages to the biotechnology sector, such as a smaller ecological footprint, adaptability, economic viability, swiftness, and management of contamination. For example, in January 2024, LondonLovesTech, a UK-based digital media and tech news publisher, reported that biotech companies and startups secured $136.3B in 2023, indicating that investment levels were sustained above those seen before the pandemic. Consequently, the swift expansion of biotechnology firms is propelling the bioprocess bag market.

What Are The Core Segment Classifications In The Biopreservation Market?

The biopreservation market covered in this report is segmented –

1) By Type: Biopreservation Equipment, Biopreservation Media

2) By Biospecimen: Human Tissue Samples, Organs, Stem Cells, Other Biospecimens

3) By Application: Therapeutic Applications, Research Applications, Clinical Trials, Other Applications

4) By End User: Biobanks, Gene Banks, Hospitals, Other End Users

Subsegments:

1) By Biopreservation Equipment: Freezers, Liquid Nitrogen Tanks, Refrigerators, Incubators

2) By Biopreservation Media: Cryoprotectants, Growth Media, Supplementary Media

Which Trends Are Expected To Shape The Biopreservation Market?

Major companies operating within the bioprocess bag market are actively developing new products, such as single-use process container films, to gain a competitive advantage in the sector. Single-use process container films are defined as flexible films or materials specifically engineered for the assembly of single-use process containers in bioprocessing and pharmaceutical manufacturing contexts. For instance, in April 2023, Merck KGaA, a pharmaceutical company based in Germany, introduced Ultimus Single-Use Process Container Film. This advanced solution was crafted to overcome challenges in bioprocessing liquid applications. Engineered with a proprietary woven nylon structure, the Ultimus film delivers exceptional durability and leak resistance, offering 10 times greater abrasion resistance, 2.8 times greater tensile strength, and twice the puncture strength compared to other single-use bioprocessing films. This innovation seeks to minimize disruptions in manufacturing operations and enhance overall operational efficiency. Furthermore, the Ultimus Single-Use Process Container Film includes an animal origin-free contact resin. This characteristic is designed to achieve a low extractable profile, thereby fulfilling stringent regulatory requirements and industry standards.

Who Are The Leading Firms Participating In The Biopreservation Market?

Major companies operating in the biopreservation market are Thermo Fisher Scientific Inc., BioLife Solutions Inc., VWR International LLC, BioCision LLC, Lifeline Scientific Inc., Biomatrica Inc., Custom Biogenic System Inc., QIAGEN NV, ThermoGenesis Holdings Inc., MVE Biological Solutions LLC, Taylor-Wharton America Inc., X-Therma Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., The Merck Group, Azenta US Inc., Avantor Inc., Bio-Techne Corporation, Worthington Industries Inc., Chart Industries Inc., Cryoport Inc., LabVantage Solutions Inc., Brooks Automation Inc., BioVault Technical Ltd., Biomatik Corporation, Biostorage Technologies Inc., Arctiko A/S, Eppendorf AG, Panasonic Healthcare Co. Ltd., BioSpherix Ltd.

Access The Complete Biopreservation Market Report:

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Which Region Leads The Biopreservation Market By Size?

North America was the largest region in the biopreservation market share in 2025. The regions covered in the biopreservation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Biopreservation Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=8263&type=smp

Browse Through More Reports Similar to the Global Biopreservation Market 2026, By The Business Research Company

Biophotonics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biophotonics-global-market-report

Biosimulation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biosimulation-global-market-report

Biochemical Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biochemical-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The CRISPR And Cas Gene Market During The Forecast Period?

The crispr and cas gene market size has seen significant expansion in recent years. It is anticipated to increase from $4.81 billion in 2025 to $5.86 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 21.8%. Historically, this expansion can be linked to the groundbreaking discovery of crispr cas systems, lower gene editing expenses, widespread adoption in academic research, the accessibility of research kits, and assistance from government funding.

The crispr and cas gene market is anticipated to experience rapid expansion over the coming years. Projections indicate it will reach $13.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.3%. This market’s growth during the projected timeframe is driven by factors such as the clinical application of gene editing, the broadening scope of personalized medicine, the emergence of new biotech startups, a rise in research funding, and improvements in delivery mechanisms. Significant trends anticipated for this period encompass the widening array of gene editing research applications, an increasing integration into cell line engineering, greater utilization in drug discovery processes, the creation of sophisticated crispr libraries, and the expansion of bespoke gene editing services.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

What Key Factors Are Affecting The CRISPR And Cas Gene Market Demand?

The increasing focus on personalized therapy is anticipated to boost the growth of the CRISPR and Cas gene markets in the future. Personalized therapy describes a medical approach that uses an individual’s genetic makeup to guide decisions regarding disease diagnosis, treatment, and prevention. CRISPR and the Cas gene, particularly Cas9, are utilized in personalized medicine, enabling precise modifications to a person’s genetic material and showing promise for breakthroughs in developing tailored therapies for genetic disorders, cancer, and various medical conditions. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based organization, reported that in 2023, the FDA approved 16 novel personalized therapies for rare disease patients, which is an increase from the six such treatments approved in 2022. Hence, the escalating demand for personalized therapy will propel the expansion of the CRISPR and Cas gene markets.

How Is The CRISPR And Cas Gene Market Broken Down By Segment Categories?

The crispr and cas gene market covered in this report is segmented –

1) By Product Type: Kits And Enzymes, Libraries, Design Tool, Antibodies, Other Products Types

2) By Service Type: Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA Synthesis

3) By Application: Clinical, Financial, Operational And Administrative

4) By End Use: Biotechnology And Pharmaceutical Companies, Academics And Government Research Institutes, Contract Research Organizations (CROs)

Subsegments:

1) By Kits And Enzymes: CRISPR Kits, Cas Enzymes, Grna Synthesis Kits

2) By Libraries: CRISPR Libraries For Gene Knockout, CRISPR Libraries For Gene Activation, Sgrna Libraries

3) By Design Tools: Online Design Platforms, Software For CRISPR Guide RNA Design, Custom Design Services

4) By Antibodies: Antibodies For Cas Proteins, Antibodies For Detection Of Edited Cells, Secondary Antibodies For Immunoassays

5) By Other Product Types: Delivery Systems, CRISPR-Related Consumables, Control Plasmids And Reagents

What Trends Are Influencing Changes In The CRISPR And Cas Gene Market?

Leading entities within the CRISPR and Cas gene markets are creating advanced products, including CRISPR-based cell-based gene therapy, to expand their product portfolios and secure a competitive edge. This therapy utilizes the CRISPR gene-editing technique to alter or mend genetic material inside cells, presenting a precise and potentially transformative method for addressing genetic disorders, illnesses, and various medical conditions directly at the cellular stage. An example of this is the approval granted by the U.S. Food and Drug Administration (FDA) in December 2023 to Vertex Pharmaceuticals Incorporated, a US-based biopharmaceutical firm, for CASGEVY (exagamglogene autotemcel [exa-cel]). CASGEVY functions as a CRISPR/Cas9 genome-edited gene therapy intended for managing sickle cell disease (SCD) in patients aged 12 and older experiencing repeated vaso-occlusive crises. This medicine represents an unprecedented class of treatment, holding the promise of a single, life-changing therapy for eligible sickle cell patients. Due to the specialized stem cell transplantation training required for CASGEVY administration, Vertex is partnering with proficient institutions to establish a network of independently operated, approved treatment centers (ATCs) throughout the United States, facilitating patient access to CASGEVY.

Which Players Are Present In The CRISPR And Cas Gene Market Space?

Major companies operating in the crispr and cas gene market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc, AstraZeneca plc, Danaher Corporation, Lonza Group AG, Bio-Rad Laboratories Inc., eGenesis, Novartis Institutes for BioMedical Research, GenScript, Takara Bio Inc., Merck KGaA, Horizon Discovery Group Plc, Beam Therapeutics Inc, Intellia Therapeutics Inc, New England BioLabs, Recursion Pharmaceuticals Inc, Caribou Biosciences Inc, Cellectis S.A., Editas Medicine Inc, CRISPR Therapeutics AG, Mammoth Biosciences, Inscripta Inc, Prime Medicine Inc, Precision BioSciences Inc, Sangamo Therapeutics Inc.

Get The Full CRISPR And Cas Gene Market Report:

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

Which Region Is The Leading Market For The CRISPR And Cas Gene Market?

North America was the largest region in the CRISPR and Cas gene market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crispr and cas gene market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized CRISPR And Cas Gene Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

Browse Through More Reports Similar to the Global CRISPR And Cas Gene Market 2026, By The Business Research Company

Plant Breeding And Crispr Plants Market Report 2026

https://www.thebusinessresearchcompany.com/report/plant-breeding-and-crispr-plants-global-market-report

Crispr Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Crispr Technology Market 2026

https://www.thebusinessresearchcompany.com/report/crispr-technology-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Biopreservation Market In 2026, And How Will Its Value Evolve By 2030?

The biopreservation market has seen rapid expansion in recent years. This market is set to increase from $6.69 billion in 2025 to $7.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.3%. The historical growth within this sector can be attributed to several factors, including the expansion of biobanking activities, an increase in clinical research studies, the growing application of biospecimens in diagnostics, the wider availability of preservation equipment, and the adoption of standardized storage protocols.

The biopreservation market is projected to experience substantial expansion in the coming years. By 2030, its value is forecast to reach $12.43 billion, advancing at a compound annual growth rate (CAGR) of 13.2%. This anticipated growth during the projection period stems from factors such as the rising need for regenerative medicine samples, the broadening scope of precision medicine research, greater financial commitments to biorepository infrastructure, a heightened emphasis on ensuring sample quality, and an increase in worldwide clinical trial activities. Key trends during this forecast period encompass the wider implementation of sophisticated cryopreservation methods, a heightened requirement for long-term biospecimen preservation solutions, the expanded application of unique biopreservation media, the growth of centralized biorepository centers, and a stronger emphasis on maintaining sample integrity and traceability.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

What Primary Drivers Are Shaping The Biopreservation Market?

The escalating demand for personalized medicine is substantially contributing to the expansion of the biopreservation market. Personalized medicine offers treatments specifically designed for individual patients based on their unique diseases. The development of these customized medicines relies on biobanks, which utilize biopreservation to preserve human tissues and cells. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Consequently, the rising demand for personalized medicine is anticipated to propel the biopreservation market growth going forward.

How Is The Biopreservation Market Broken Down By Segment Categories?

The biopreservation market covered in this report is segmented –

1) By Type: Biopreservation Equipment, Biopreservation Media

2) By Biospecimen: Human Tissue Samples, Organs, Stem Cells, Other Biospecimens

3) By Application: Therapeutic Applications, Research Applications, Clinical Trials, Other Applications

4) By End User: Biobanks, Gene Banks, Hospitals, Other End Users

Subsegments:

1) By Biopreservation Equipment: Freezers, Liquid Nitrogen Tanks, Refrigerators, Incubators

2) By Biopreservation Media: Cryoprotectants, Growth Media, Supplementary Media

What Trends Are Affecting The Growth Of The Biopreservation Market?

Major companies active in the biopreservation market are concentrating on developing innovative solutions, such as cryopreservation techniques, to fulfill the growing demand for preserving complex tissues and organs over extended periods. Cryopreservation is the method of safeguarding biological material at extremely low temperatures (-196°C), either very quickly, as seen in seed storage, or gradually with controlled dehydration. This process offers advantages over traditional storage methods by maintaining viability and functionality for longer durations. For instance, in April 2024, Pluristyx, Inc., a US-based biotechnology company, launched PluriFreeze Cryopreservation Media. This product is designed to enhance the viability and functionality of human-derived pluripotent stem cells (iPSCs) and other delicate cell types during freezing and thawing. PluriFreeze consists entirely of synthetic and animal-origin-free (AOF) materials. Its low viscosity supports automation and large-scale cell production, while the complementary DMSO-free wash solution, PluriPrep, allows for extended processing times, thereby optimizing cell handling and recovery for research and clinical applications.

Which Players Are Present In The Biopreservation Market Space?

Major companies operating in the biopreservation market are Thermo Fisher Scientific Inc., BioLife Solutions Inc., VWR International LLC, BioCision LLC, Lifeline Scientific Inc., Biomatrica Inc., Custom Biogenic System Inc., QIAGEN NV, ThermoGenesis Holdings Inc., MVE Biological Solutions LLC, Taylor-Wharton America Inc., X-Therma Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., The Merck Group, Azenta US Inc., Avantor Inc., Bio-Techne Corporation, Worthington Industries Inc., Chart Industries Inc., Cryoport Inc., LabVantage Solutions Inc., Brooks Automation Inc., BioVault Technical Ltd., Biomatik Corporation, Biostorage Technologies Inc., Arctiko A/S, Eppendorf AG, Panasonic Healthcare Co. Ltd., BioSpherix Ltd.

Get The Full Biopreservation Market Report:

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Where Is The Biopreservation Market Primarily Concentrated By Region?

North America was the largest region in the biopreservation market share in 2025. The regions covered in the biopreservation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Biopreservation Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Browse Through More Reports Similar to the Global Biopreservation Market 2026, By The Business Research Company

Biochemical Market Report 2026

https://www.thebusinessresearchcompany.com/report/biochemical-global-market-report

Biophotonics Market Report 2026

https://www.thebusinessresearchcompany.com/report/biophotonics-global-market-report

Biosimulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biosimulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Biopreservation Market In 2026, And How Will Its Value Evolve By 2030?

The biopreservation market has seen rapid expansion in recent years. This market is set to increase from $6.69 billion in 2025 to $7.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.3%. The historical growth within this sector can be attributed to several factors, including the expansion of biobanking activities, an increase in clinical research studies, the growing application of biospecimens in diagnostics, the wider availability of preservation equipment, and the adoption of standardized storage protocols.

The biopreservation market is projected to experience substantial expansion in the coming years. By 2030, its value is forecast to reach $12.43 billion, advancing at a compound annual growth rate (CAGR) of 13.2%. This anticipated growth during the projection period stems from factors such as the rising need for regenerative medicine samples, the broadening scope of precision medicine research, greater financial commitments to biorepository infrastructure, a heightened emphasis on ensuring sample quality, and an increase in worldwide clinical trial activities. Key trends during this forecast period encompass the wider implementation of sophisticated cryopreservation methods, a heightened requirement for long-term biospecimen preservation solutions, the expanded application of unique biopreservation media, the growth of centralized biorepository centers, and a stronger emphasis on maintaining sample integrity and traceability.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

What Primary Drivers Are Shaping The Biopreservation Market?

The escalating demand for personalized medicine is substantially contributing to the expansion of the biopreservation market. Personalized medicine offers treatments specifically designed for individual patients based on their unique diseases. The development of these customized medicines relies on biobanks, which utilize biopreservation to preserve human tissues and cells. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Consequently, the rising demand for personalized medicine is anticipated to propel the biopreservation market growth going forward.

How Is The Biopreservation Market Broken Down By Segment Categories?

The biopreservation market covered in this report is segmented –

1) By Type: Biopreservation Equipment, Biopreservation Media

2) By Biospecimen: Human Tissue Samples, Organs, Stem Cells, Other Biospecimens

3) By Application: Therapeutic Applications, Research Applications, Clinical Trials, Other Applications

4) By End User: Biobanks, Gene Banks, Hospitals, Other End Users

Subsegments:

1) By Biopreservation Equipment: Freezers, Liquid Nitrogen Tanks, Refrigerators, Incubators

2) By Biopreservation Media: Cryoprotectants, Growth Media, Supplementary Media

What Trends Are Affecting The Growth Of The Biopreservation Market?

Major companies active in the biopreservation market are concentrating on developing innovative solutions, such as cryopreservation techniques, to fulfill the growing demand for preserving complex tissues and organs over extended periods. Cryopreservation is the method of safeguarding biological material at extremely low temperatures (-196°C), either very quickly, as seen in seed storage, or gradually with controlled dehydration. This process offers advantages over traditional storage methods by maintaining viability and functionality for longer durations. For instance, in April 2024, Pluristyx, Inc., a US-based biotechnology company, launched PluriFreeze Cryopreservation Media. This product is designed to enhance the viability and functionality of human-derived pluripotent stem cells (iPSCs) and other delicate cell types during freezing and thawing. PluriFreeze consists entirely of synthetic and animal-origin-free (AOF) materials. Its low viscosity supports automation and large-scale cell production, while the complementary DMSO-free wash solution, PluriPrep, allows for extended processing times, thereby optimizing cell handling and recovery for research and clinical applications.

Which Players Are Present In The Biopreservation Market Space?

Major companies operating in the biopreservation market are Thermo Fisher Scientific Inc., BioLife Solutions Inc., VWR International LLC, BioCision LLC, Lifeline Scientific Inc., Biomatrica Inc., Custom Biogenic System Inc., QIAGEN NV, ThermoGenesis Holdings Inc., MVE Biological Solutions LLC, Taylor-Wharton America Inc., X-Therma Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., The Merck Group, Azenta US Inc., Avantor Inc., Bio-Techne Corporation, Worthington Industries Inc., Chart Industries Inc., Cryoport Inc., LabVantage Solutions Inc., Brooks Automation Inc., BioVault Technical Ltd., Biomatik Corporation, Biostorage Technologies Inc., Arctiko A/S, Eppendorf AG, Panasonic Healthcare Co. Ltd., BioSpherix Ltd.

Get The Full Biopreservation Market Report:

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Where Is The Biopreservation Market Primarily Concentrated By Region?

North America was the largest region in the biopreservation market share in 2025. The regions covered in the biopreservation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Biopreservation Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Browse Through More Reports Similar to the Global Biopreservation Market 2026, By The Business Research Company

Biochemical Market Report 2026

https://www.thebusinessresearchcompany.com/report/biochemical-global-market-report

Biophotonics Market Report 2026

https://www.thebusinessresearchcompany.com/report/biophotonics-global-market-report

Biosimulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biosimulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Biopreservation Market Between 2026 And 2030?

The biopreservation market has experienced significant expansion in recent years. It is projected to increase from $6.69 billion in 2025 to $7.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.3%. This historical growth can be attributed to several factors such as the expansion of biobanking activities, an increase in clinical research studies, the rising utilization of biospecimens in diagnostics, enhanced availability of preservation equipment, and the implementation of standardized storage protocols.

The biopreservation market is anticipated to experience substantial growth in the upcoming years, with its valuation predicted to reach $12.43 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.2%.

This projected growth throughout the forecast period stems from factors such as increasing demand for regenerative medicine samples, the expansion of precision medicine research, a rise in investments toward biorepository infrastructure, a heightened emphasis on sample quality assurance, and an increase in global clinical trial activities.

Prominent trends expected during this forecast period include the increasing adoption of advanced cryopreservation techniques, a rising demand for solutions for long-term biospecimen storage, the growing use of specialized biopreservation media, the expansion of centralized biorepository facilities, and an enhanced focus on maintaining sample integrity and traceability.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8263&type=smp

What Major Drivers Are Influencing Demand In The Biopreservation Market?

The growing need for personalized medicine is a significant factor contributing to the expansion of the biopreservation market. This medical approach treats patients for diseases specific to their individual conditions. Personalized medicines are developed with the assistance of biobanks, which preserve human tissues and cells through biopreservation techniques. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that the FDA authorized 16 novel personalized therapies for patients with rare diseases in 2023, a notable rise from six such approvals in 2022. Therefore, the increasing demand for personalized medicine is projected to drive the biopreservation market’s growth in the foreseeable future.

Which Market Segments Are Examined In The Biopreservation Market Study?

The biopreservation market covered in this report is segmented –

1) By Type: Biopreservation Equipment, Biopreservation Media

2) By Biospecimen: Human Tissue Samples, Organs, Stem Cells, Other Biospecimens

3) By Application: Therapeutic Applications, Research Applications, Clinical Trials, Other Applications

4) By End User: Biobanks, Gene Banks, Hospitals, Other End Users

Subsegments:

1) By Biopreservation Equipment: Freezers, Liquid Nitrogen Tanks, Refrigerators, Incubators

2) By Biopreservation Media: Cryoprotectants, Growth Media, Supplementary Media

Which Upcoming Trends Are Expected To Influence The Biopreservation Market?

Major companies operating in the biopreservation market are prioritizing the development of innovative solutions, such as cryopreservation solutions, to address the growing need for preserving complex tissues and organs over time. Cryopreservation is a technique for safeguarding biological material at extremely low temperatures (-196°C), either rapidly (as seen in seed storage) or gradually through controlled dehydration, providing superior benefits over traditional storage methods by maintaining viability and functionality for longer periods. For instance, in April 2024, Pluristyx, Inc., a US-based biotechnology company, unveiled PluriFreeze Cryopreservation Media, engineered to improve the viability and functionality of human-derived pluripotent stem cells (iPSCs) and other delicate cell types during freezing and thawing. PluriFreeze consists entirely of synthetic and animal-origin-free (AOF) materials. Its low viscosity supports automation and large-scale cell production, while the complementary DMSO-free wash solution, PluriPrep, allows for extended processing times, thereby optimizing cell handling and recovery for research and clinical applications.

Who Are The Primary Competitors In The Biopreservation Market?

Major companies operating in the biopreservation market are Thermo Fisher Scientific Inc., BioLife Solutions Inc., VWR International LLC, BioCision LLC, Lifeline Scientific Inc., Biomatrica Inc., Custom Biogenic System Inc., QIAGEN NV, ThermoGenesis Holdings Inc., MVE Biological Solutions LLC, Taylor-Wharton America Inc., X-Therma Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., The Merck Group, Azenta US Inc., Avantor Inc., Bio-Techne Corporation, Worthington Industries Inc., Chart Industries Inc., Cryoport Inc., LabVantage Solutions Inc., Brooks Automation Inc., BioVault Technical Ltd., Biomatik Corporation, Biostorage Technologies Inc., Arctiko A/S, Eppendorf AG, Panasonic Healthcare Co. Ltd., BioSpherix Ltd.

Read the full biopreservation market report here:

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Biopreservation Market?

North America was the largest region in the biopreservation market share in 2025. The regions covered in the biopreservation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biopreservation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8263&type=smp

Browse Through More Reports Similar to the Global Biopreservation Market 2026, By The Business Research Company

Biophotonics Global Market Report

https://www.thebusinessresearchcompany.com/report/biophotonics-global-market-report

Biosimulation Global Market Report

https://www.thebusinessresearchcompany.com/report/biosimulation-global-market-report

Biochemical Global Market Report

https://www.thebusinessresearchcompany.com/report/biochemical-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model